This page shows the latest European Union news and features for those working in and with pharma, biotech and healthcare.
European Union leaders met yesterday to discuss possible COVID-19 vaccine export measures in a bid to bolster the bloc’s roll-out of jabs to its citizens. ... Because that proves that the European Union is the most open reliably exporting region in the
Johnson &Johnson’s (J&J) single-dose COVID-19 vaccine has scored a conditional marketing authorisation (CMA) from the European Commission, the company announced yesterday. . ... An EU official told Reuters that J&J had informed the European Union
reported. An EU official told Reuters that J&J informed the European Union that it is currently experiencing supply issues that could impact its delivery commitments to the EU in the ... We stand ready to begin distributing our vaccine within the
Using this approach, the analysis found that five countries – Australia, Canada, Japan, the UK and the US – plus the European Union, that is made up of 27 member states, could share
Pfizer/BioNTech and Moderna are set to increase supplies of their respective COVID-19 vaccines to the European Union (EU), according to two separate announcements detailing the new agreements this week. ... In a statement published on Wednesday (17
Throughout Europe, there remains an urgent need for additional COVID-19 vaccines, and [this] submission is a significant step forward in ensuring the European Union has another option to help reduce ... We stand ready to begin distributing our vaccine
More from news
Approximately 5 fully matching, plus 304 partially matching documents found.
This was the first trade deal reached by the United Kingdom following its departure from the European Union. ... Perhaps unsurprisingly, London is the most popular European city for Japanese residents to live in overseas and therefore gives a clear
risks. The ongoing and unprecedented public health crisis caused by COVID-19 has overstretched the structures and mechanisms of the European Union, especially those that deal with emergencies. ... Due to its financial innovation, not only does it
In the European Union, the Orphan Drug Regulation was adopted in 2000. ... Support success. According to Lavinia Meloni, spokeswoman for the European Federation of Pharmaceutical Industries and Associations, efforts to encourage development of drugs for
By Emma Eatwell. In March 2020 the European Commission presented its ‘New Industrial Strategy for Europe’, which proposes to move the European Union towards climate neutrality and digital leadership. ... The European Public Health Alliance says the
Why pharma M&A has continually bucked the trend. Now that the UK has finally officially left the European Union, and with the dust having settled on a tumultuous end to ... But the one additional point I would make is to not assume the European or North
More from intelligence
Approximately 1 fully matching, plus 45 partially matching documents found.
Dr Hoerr said: “It is a tremendous honor to be selected by the European Commission as member of the High Level Group focused on advancing innovation throughout the European Union. ... Governing board member of the European Institute for Innovation and
Lisa will play a leading role as we negotiate the future of our industry outside the European Union and as we work with government to build an industrial strategy with
Andreas Walter brings experience from the EFPIA. The European Medicines Verification Organisation (EMVO) has appointed Andreas Walter as its general manager. ... It was established last year by industry organisations, including EFPIA, and the European
The European Medicines Verification Organisation (EMVO) has appointed Sonia Ruiz Moran as its new president, replacing John Chave, former secretary general of Pharmaceutical Group of the European Union (PGEU). ... She said: “The planning and design of
De Garidel has been chairman and CEO of Ipsen, which specialises in neurology, endocrinology and urology-oncology, since 2010 and he chaired the European Biopharmaceutical Enterprises Association from 2010-12. ... The IMI is a public-private partnership
More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.
France is the second largest economy in the European Union and one of the largest consumers of pharmaceutical products in the world. ... As a member of the network, PRPA will work collaboratively alongside London-based European hub partner Aurora
On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and
HIGHLIGHTS INCLUDE:. Opportunities and threats of digital therapeutics after COVID-19. Digital therapeutics landscape in the European Union.
The European Commission’s Pharmaceutical Strategy has been published and the Commission has presented its priorities for the coming years. ... On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of
The European Union alone spends 700bn (£624 bn) annually on chronic disease management.
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...